Levothyroxine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Levothyroxine (synthetic T4) is the standard treatment for hypothyroidism and is one of the most prescribed medications worldwide. It replaces or supplements deficient thyroid hormone, restoring normal metabolic function. It is also used for thyroid-stimulating hormone (TSH) suppression in thyroid cancer management. Consistent daily dosing on an empty stomach is essential for reliable absorption.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Levothyroxine (synthetic T4) is the standard treatment for hypothyroidism and is one of the most prescribed medications worldwide. NutriStack rates the supporting evidence as strong. Common adult dosing is 25–200 mcg daily; typical full replacement 1.6 mcg/kg/day (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 13 sources.
- Signs of overreplacement: tachycardia, palpitations, tremor, anxiety, insomnia, heat intolerance
- Weight loss (if over-replaced)
- Headache
- Untreated adrenal insufficiency (must replace cortisol first to avoid adrenal crisis)
- Acute myocardial infarction (unless hypothyroidism is a complicating factor)
The bottom line
Evidence rating strong. Most-documented uses: restores normal thyroid hormone levels in hypothyroidism, resolves symptoms of hypothyroidism (fatigue, weight gain, cold intolerance, cognitive sluggishness), normalizes tsh levels. 13 sources indexed (2022–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Synthetic thyroxine (T4) that is peripherally converted to the active hormone triiodothyronine (T3) by deiodinase enzymes. T3 binds to nuclear thyroid hormone receptors, forming a complex that activates gene transcription involved in protein synthesis, oxygen consumption, basal metabolic rate regulation, carbohydrate and lipid metabolism, and growth and development.9
Dosing & protocol.
Take on an empty stomach 30–60 minutes before breakfast, or at bedtime 3+ hours after the last meal. Avoid calcium, iron, antacids, and coffee within 4 hours as they impair absorption. Consistency is critical.
Full safety detail.
Side effects
- Signs of overreplacement: tachycardia, palpitations, tremor, anxiety, insomnia, heat intolerance
- Weight loss (if over-replaced)
- Headache
- Hair loss (transient, usually early in treatment)
- Bone density loss with chronic excessive dosing
- Angina or arrhythmia in susceptible patients
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
7- 1Effects of Levothyroxine Treatment on Fertility and Pregnancy Outcomes in Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPMIDSankoda A, Suzuki H, Imaizumi M, Yoshihara A et al. · Thyroid · 2024
Levothyroxine treatment in women with subclinical hypothyroidism was associated with improved pregnancy rates and reduced miscarriage rates in this meta-analysis of RCTs
- 2Systematic review and meta-analysis of levothyroxine effect on blood pressure in patients with subclinical hypothyroidismPMIDDarouei B, Amani-Beni R, Abhari AP, Fakhrolmobasheri M et al. · Current Problems in Cardiology · 2024
Levothyroxine treatment in subclinical hypothyroidism was associated with modest but significant reductions in both systolic and diastolic blood pressure
- 3Levothyroxine for subclinical hypothyroidism during pregnancy: an updated systematic review and meta-analysis of randomized controlled trialsPMIDProvinciatto H, Moreira MVB, Neves GR et al. · Archives of gynecology and obstetrics · 2024
Provinciatto H, Moreira MVB, Neves GR et al.. Levothyroxine for subclinical hypothyroidism during pregnancy: an updated systematic review and meta-analysis of randomized controlled trials. Archives of gynecology and obstetrics. 2024
- 4Cardiovascular and bone health outcomes in older people with subclinical hypothyroidism treated with levothyroxine: a systematic review and meta-analysisPMIDHolley M, Razvi S, Farooq MS et al. · Systematic reviews · 2024
Holley M, Razvi S, Farooq MS et al.. Cardiovascular and bone health outcomes in older people with subclinical hypothyroidism treated with levothyroxine: a systematic review and meta-analysis. Systematic reviews. 2024
- 5LT4/LT3 Combination Therapy vs. Monotherapy with LT4 for Persistent Symptoms of Hypothyroidism: A Systematic ReviewPMIDVargas-Uricoechea H, Wartofsky L · International journal of molecular sciences · 2024
Vargas-Uricoechea H, Wartofsky L. LT4/LT3 Combination Therapy vs. Monotherapy with LT4 for Persistent Symptoms of Hypothyroidism: A Systematic Review. International journal of molecular sciences. 2024
- 6Idiopathic Intracranial Hypertension following Levothyroxine Replacement Therapy: Systematic Review and a Case ReportPMIDDatta SG, S L SR, Dhananjaya MS et al. · Indian journal of endocrinology and metabolism · 2023
Datta SG, S L SR, Dhananjaya MS et al.. Idiopathic Intracranial Hypertension following Levothyroxine Replacement Therapy: Systematic Review and a Case Report. Indian journal of endocrinology and metabolism. 2023
- 7Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic ReviewPMIDLiu H, Lu M, Hu J et al. · Therapeutics and clinical risk management · 2023
Liu H, Lu M, Hu J et al.. Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review. Therapeutics and clinical risk management. 2023
Reviews & position papers
1- 8Treating hypothyroidism is not always easy: When to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapyPMIDRoss DS · Journal of Internal Medicine · 2022
Treatment of subclinical hypothyroidism with levothyroxine should be individualized based on TSH level, age, symptoms, and comorbidities; combination therapy with liothyronine may benefit some patients
Reference material
5- 9Jonklaas J et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751.Source linkedPMID
- 10Garber JR et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235.Source linkedPMID
- 11Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab. 2012;97(7):2256-2271.Source linkedPMID
- 12Wiesner A, Gajewska D, Paśko P. Levothyroxine Interactions with Food and Dietary Supplements-A Systematic Review. Pharmaceuticals (Basel, Switzerland). 2021Source linkedPMID
- 13Skelin M, Lucijanić T, Amidžić Klarić D et al.. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. Clinical therapeutics. 2017Source linkedPMID
Common questions.
Quick answers about Levothyroxine, drawn from the data on this page.
What is Levothyroxine?
Levothyroxine (synthetic T4) is the standard treatment for hypothyroidism and is one of the most prescribed medications worldwide. It replaces or supplements deficient thyroid hormone, restoring normal metabolic function. It is also used for thyroid-stimulating hormone (TSH) suppression in thyroid cancer management. Consistent daily dosing on an empty stomach is essential for reliable absorption.
What is Levothyroxine used for?
Commonly cited benefits of Levothyroxine include: Restores normal thyroid hormone levels in hypothyroidism; Resolves symptoms of hypothyroidism (fatigue, weight gain, cold intolerance, cognitive sluggishness); Normalizes TSH levels; TSH suppression in thyroid cancer management; Well-established safety profile with decades of use. NutriStack rates the overall evidence as strong.
What is a typical dose of Levothyroxine?
A typical adult dose of Levothyroxine is 25–200 mcg daily; typical full replacement 1.6 mcg/kg/day (as prescribed by your physician). The commonly recommended form is Oral tablet; soft gel capsule (Tirosint) for patients with absorption issues. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Levothyroxine?
Reported side effects include signs of overreplacement: tachycardia, palpitations, tremor, anxiety, insomnia, heat intolerance, weight loss (if over-replaced), headache, hair loss (transient, usually early in treatment), bone density loss with chronic excessive dosing, angina or arrhythmia in susceptible patients. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Levothyroxine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Levothyroxine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.